{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:15:53Z","timestamp":1759540553391,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.arcmed.2009.09.003","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T05:09:32Z","timestamp":1260940172000},"page":"527-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Repeated Dose Toxicity Study of a Live Attenuated Oral Cholera Vaccine in\u00a0Sprague Dawley Rats"],"prefix":"10.1016","volume":"40","author":[{"given":"Sergio","family":"Sifontes-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Francisco","family":"Infante-Bourzac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiyana","family":"D\u00edaz-Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulie\u00e9","family":"L\u00f3pez-Feria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merlin","family":"P\u00e9rez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eligio","family":"Sosa-Roble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"P\u00e9rez-Amat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamil\u00e9","family":"L\u00f3pez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"\u00c1lvarez-Figueredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Mart\u00ednez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mildrey","family":"Fari\u00f1as-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Hern\u00e1ndez-Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolexis","family":"Tamayo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Vald\u00e9s-Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Ponce-Collera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niurka","family":"Rodr\u00edguez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2009.09.003_bib1","unstructured":"World Health Organization. Wkly Epidemiol Rec 2005;80:261\u2013268."},{"key":"10.1016\/j.arcmed.2009.09.003_bib2","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1016\/j.vaccine.2005.12.064","article-title":"Formulation in tablets of a cholera whole cell inactivated vaccine candidate","volume":"24","author":"Talavera","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.09.003_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/IAI.67.2.539-545.1999","article-title":"Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin\/protease-defective El Tor strain as a cholera vaccine candidate","volume":"67","author":"Ben\u00edtez","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.arcmed.2009.09.003_bib4","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1099\/mic.0.26086-0","article-title":"Haemagglutinin\/protease expression and mucin gel penetration in El Tor biotype Vibrio cholerae","volume":"149","author":"Silva","year":"2003","journal-title":"Microbiology"},{"key":"10.1016\/j.arcmed.2009.09.003_bib5","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2003.12.033","article-title":"Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR","volume":"22","author":"Viret","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.09.003_bib6","first-page":"92","article-title":"Selecci\u00f3n de cepas atenuadas de Vibrio cholerae para la obtenci\u00f3n de candidatos vacunales atenuados orales contra el c\u00f3lera","volume":"57","author":"Garc\u00eda","year":"2005","journal-title":"Rev Cubana Med Trop"},{"key":"10.1016\/j.arcmed.2009.09.003_bib7","unstructured":"Sutkowski E. Non-Clinical Safety Assessment of Preventive Vaccines, the FDA Perspective. Proc Workshop on Non-Clinical Safety Evaluation of Preventive Vaccines: Recent Advances and Regulatory Considerations. December 2, 2002; Arlington, VA."},{"key":"10.1016\/j.arcmed.2009.09.003_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0273-2300(05)80052-2","article-title":"Extrapolation of animal toxicity to humans: interspecies comparisons in drug development","volume":"12","author":"Voisin","year":"1990","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.arcmed.2009.09.003_bib9","unstructured":"Human Medicines Evaluation Unit. The European Agency for the Evaluation of Medicinal Products (EMEA). Note for Guidance on Preclinical Pharmacological and Toxicological Testing of Vaccines. London; 17 December 1997. Report No. CPMP\/SWP\/465\/95."},{"key":"10.1016\/j.arcmed.2009.09.003_bib10","first-page":"34","article-title":"Non-clinical Safety Evaluation of Preventive Vaccines\u2014Regulatory Considerations","author":"Sutkowski","year":"2003","journal-title":"Business Briefing: Future Drug Discovery"},{"key":"10.1016\/j.arcmed.2009.09.003_bib11","first-page":"17","article-title":"Guidelines on Nonclinical Evaluation of Vaccines. WHO Technical Report Series","author":"World Health Organization","year":"2003","journal-title":"Adopted by the 54th meeting of the WHO Expert Committee on Biological Standardization"},{"key":"10.1016\/j.arcmed.2009.09.003_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0264-410X(97)88330-2","article-title":"Immunogenicity and protective role of three formulations of oral cholera vaccines","volume":"16","author":"Thareert","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.09.003_bib13","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/S0264-410X(00)00101-8","article-title":"Local and systemic immune responses to combined Vibrio cholerae CVD103-HgR and Salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization","volume":"18","author":"Kollaritsch","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.09.003_bib14","unstructured":"Verdier F. Non-Clinical Safety Assessment of Preventive Vaccines, the Industry Perspective. Proceeding of the Workshop on Non-Clinical Safety Evaluation of Preventive Vaccines: Recent Advances and Regulatory Considerations; December 2, 2002; Arlington, VA."},{"key":"10.1016\/j.arcmed.2009.09.003_bib15","unstructured":"Charles River Laboratories, Inc. Charles River Labs\u2014Research Models: Sprague Dawley Rat Informational Resources. http:\/\/www.criver.com\/research_models_and_services\/research_models\/SASCO_Sprague_Dawley.html [16 May 2006]."},{"key":"10.1016\/j.arcmed.2009.09.003_bib16","unstructured":"National Bio Resource Project for the Rat in Japan (http:\/\/www.anim.med.kyoto-u.ac.jp\/nbr\/strainsx\/hematology_list.aspx) [12 April 2006]."},{"key":"10.1016\/j.arcmed.2009.09.003_bib17","unstructured":"Pritchett KR. Biology and Medicine of Rats: International Veterinary Information Service, Ithaca, NY; 2004."},{"key":"10.1016\/j.arcmed.2009.09.003_bib18","unstructured":"Taconic Technical Library. Taconic Sprague Dawley Phenotyping. (http:\/\/www.taconic.com\/addinfo\/SD_phenotyping.htm) [12 May 2006]."},{"key":"10.1016\/j.arcmed.2009.09.003_bib19","first-page":"289","article-title":"Pathophysiology of reactions associated with pertussis vaccine","volume":"73","author":"Blumberg","year":"1991","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.arcmed.2009.09.003_bib20","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1086\/313866","article-title":"Clinical considerations in designing trials of vaccines for tuberculosis","volume":"30","author":"Glassroth","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arcmed.2009.09.003_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0264-410X(92)90086-Y","article-title":"Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382)","volume":"10","author":"Kaji","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.09.003_bib22","first-page":"118","article-title":"Leukemoid reaction or leukosis after MMR preventive vaccination","volume":"61","author":"Wiersbitzky","year":"1993","journal-title":"Kinderarztl Prax"},{"key":"10.1016\/j.arcmed.2009.09.003_bib23","first-page":"848","article-title":"Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite","volume":"24","author":"Soderberg","year":"1996","journal-title":"Exp Hematol"},{"key":"10.1016\/j.arcmed.2009.09.003_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1440-1797.2005.00494.x","article-title":"Propylthiouracil attenuates acetaminophen-induced renal damage in the rat","volume":"10","author":"Abraham","year":"2005","journal-title":"Nephrology"},{"key":"10.1016\/j.arcmed.2009.09.003_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1440-1681.2004.04050.x","article-title":"Effects of caffeic acid phenethyl ester on glycerol-induced acute renal failure in rats","volume":"31","author":"Aydogdu","year":"1998","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.arcmed.2009.09.003_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000045249","article-title":"Tetracycline-induced acute interstitial nephritis as a cause of acute renal failure","volume":"81","author":"Bihorac","year":"1999","journal-title":"Nephron"},{"key":"10.1016\/j.arcmed.2009.09.003_bib27","first-page":"551","article-title":"Induction of interstitial nephritis in rats by basement membrane of human origin","volume":"39","author":"Joh","year":"1989","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.arcmed.2009.09.003_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jat.962","article-title":"Effect of milk on intestinal fluid accumulation and renal injury following mercuric chloride ingestion in rats","volume":"24","author":"Kamijo","year":"2004","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.arcmed.2009.09.003_bib29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tox.2005.07.007","article-title":"Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats","volume":"215","author":"Karahan","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.arcmed.2009.09.003_bib30","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1097\/01.ASN.0000128968.27705.5E","article-title":"Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-gamma","volume":"15","author":"Kitching","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.arcmed.2009.09.003_bib31","first-page":"351","article-title":"Antihepatotoxic effect of beta-carotene on paracetamol induced hepatic damage in rats","volume":"43","author":"Kumar","year":"2005","journal-title":"Indian J\u00a0Exp Biol"},{"key":"10.1016\/j.arcmed.2009.09.003_bib32","first-page":"1","article-title":"Acute and subchronic (28-day) oral toxicity study in rats fed with novel surfactants","volume":"6","author":"Madhukar","year":"2004","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.arcmed.2009.09.003_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tox.2005.02.013","article-title":"Effect of cysteine, methionine, ascorbic acid and thiamine on arsenic-induced oxidative stress and biochemical alterations in rats","volume":"211","author":"Nandi","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.arcmed.2009.09.003_bib34","first-page":"5444","article-title":"Hepatic fibrosis in biliary-obstructed rats is prevented by ginkgo biloba treatment","author":"Sener","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2009.09.003_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cca.2005.07.032","article-title":"Effect of squalene on cyclophosphamide-induced toxicity","volume":"11","author":"Senthilkumar","year":"2006","journal-title":"Clin Chem Acta"},{"key":"10.1016\/j.arcmed.2009.09.003_bib36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.33549\/physiolres.930400","article-title":"Estrogen effect on some enzymes in female rats after downhill running","volume":"52","author":"Sotiriadou","year":"2003","journal-title":"Physiol Res"},{"key":"10.1016\/j.arcmed.2009.09.003_bib37","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1248\/bpb.28.1304","article-title":"Reversal of fibrogenic events in liver by Emblica officinalis (fruit), an Indian natural drug","volume":"28","author":"Tasduq","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.arcmed.2009.09.003_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1742-7843.2004.950305.x","article-title":"Protective effects of vitamin A and vitamin E succinate against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced body wasting, hepatomegaly, thymic atrophy, production of reactive oxygen species and DNA damage in C57BL\/6J mice","volume":"95","author":"Alsharif","year":"2004","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.arcmed.2009.09.003_bib39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.micpath.2005.08.005","article-title":"Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4 + CD8+ thymocyte depletion","volume":"39","author":"Chen","year":"2005","journal-title":"Microb Pathog"},{"key":"10.1016\/j.arcmed.2009.09.003_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/exmp.2000.2346","article-title":"Tubular cell senescence and expression of TGF-beta1 and p21 (WAF1\/CIP1) in tubulointerstitial fibrosis of aging rats","volume":"70","author":"Ding","year":"2001","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.arcmed.2009.09.003_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-2478(97)00152-1","article-title":"Administration of one dose of cholera toxin induces a systemic immune response prior to a mucosal immune response by a direct presentation in the spleen","volume":"60","author":"Benedetti","year":"1998","journal-title":"Immunol Lett"},{"key":"10.1016\/j.arcmed.2009.09.003_bib42","first-page":"312","article-title":"Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia","volume":"29","author":"Concha","year":"1995","journal-title":"Bull Pan Am Health Organ"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440909001611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440909001611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:36:39Z","timestamp":1759260999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440909001611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0188440909001611"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2009.09.003","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated Dose Toxicity Study of a Live Attenuated Oral Cholera Vaccine in\u00a0Sprague Dawley Rats","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2009.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}